Shaily Engineering Plastics Bags Rs 423 Cr Pharma Deal

Shaily Engineering Plastics rose 3.57% today to Rs 2,008.55 after the company secured a major manufacturing and commercial supply agreement worth around Rs 423 crore.

The order, awarded by a large domestic pharmaceutical company, involves the supply of pen injectors over a four-year period. The development boosted investor sentiment and lifted the stock in intraday trade.

In an exchange filing, the company said the customer’s name has not been disclosed due to confidentiality reasons. The contract has been awarded by a domestic entity and covers the manufacturing and commercial supply of pen injectors.

Also Read: Smart Manufacturing: From Connected Units to Cognitive Businesses

Shaily Engineering Plastics clarified that neither the promoter nor the promoter group has any interest in the awarding entity. It also stated that the contract does not fall under related party transactions.

CLICK HERE TO CATCH THE LATEST INDUSTRY STORIES

The deal strengthens the company’s presence in the pharmaceutical delivery devices segment and adds long-term revenue visibility. The order size highlights growing demand for advanced drug delivery solutions in the domestic market.

Shaily Engineering Plastics manufactures injection-molded precision plastic components and sub-assemblies for various requirements of Original Equipment Manufacturers (OEMs).

On the financial front, the company reported strong quarterly numbers. Consolidated net profit jumped 48.3% to Rs 37.38 crore in Q3 FY26, compared with Q3 FY25. Revenue from operations rose 26.8% year-on-year to Rs 250.50 crore, reflecting steady business momentum.